These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Erythropoietin therapy in renal failure. Paganini EP; Miller T Adv Intern Med; 1993; 38():223-43. PubMed ID: 8438638 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin for anemia. Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624 [No Abstract] [Full Text] [Related]
8. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin. Verbeelen D; Hauglustaine D; Sennesael J Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012 [No Abstract] [Full Text] [Related]
9. A probable conformational difference between recombinant and urinary erythropoietins. Kung CK; Goldwasser E Proteins; 1997 May; 28(1):94-8. PubMed ID: 9144794 [TBL] [Abstract][Full Text] [Related]
10. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO? Besarab A; McCrea JB ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674 [No Abstract] [Full Text] [Related]
11. Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin. Birgegård G; Gudbjrönsson B; Hällgren R; Wide L Contrib Nephrol; 1991; 88():295-303; discussion 304-5. PubMed ID: 2040192 [No Abstract] [Full Text] [Related]
14. [Treatment of anemia in premature infants using recombinant human erythropoietin]. de Haas V; Raaijmaakers BC; Semmekrot BA; Kollée LA Ned Tijdschr Geneeskd; 1995 Apr; 139(15):773-6. PubMed ID: 7723878 [No Abstract] [Full Text] [Related]
15. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group. Keown PA Contrib Nephrol; 1991; 88():81-6; discussion 87-9. PubMed ID: 2040199 [No Abstract] [Full Text] [Related]
16. [Application of recombinant human erythropoietin on cardiac surgery]. Hayashi J; Shinonaga M; Eguchi S; Shinada S Kokyu To Junkan; 1992 Aug; 40(8):751-7. PubMed ID: 1529171 [No Abstract] [Full Text] [Related]
17. Chronic anemia after lung transplantation: treatment with human recombinant erythropoietin. End A; Ringl H; Grimm M; Schlick W; Schreiner W; Klepetko W; Wolner E Transplantation; 1994 Apr; 57(7):1142. PubMed ID: 8165717 [No Abstract] [Full Text] [Related]
18. [Recombinant human erythropoietin in uremic patients in substitute treatment]. Canaud B; Mion C Rev Prat; 1992 Feb; 42(4):432-40. PubMed ID: 1604162 [TBL] [Abstract][Full Text] [Related]
19. Erythropoietin: in vitro and in vivo studies of the regulation of erythropoiesis. Adamson JW Schweiz Med Wochenschr; 1988 Oct; 118(42):1501-6. PubMed ID: 2849202 [TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients. Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199 [No Abstract] [Full Text] [Related] [Next] [New Search]